Search

28/11/2025 Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Muñoz-Vendrell, A, Campoy-Díaz, S, Valín-Villanueva, P, Casas-Limón, J, Fernández-Lázaro, I, González-García, N, Santos-Lasaosa, S, Osorio, YG, Gonzalez-Martinez, A, Campdelacreu, J, Portocarrero-Sánchez, L, Sánchez, LMC, Sánchez, SMG, Pérez-de-la-parte, A, Sánchez-Mateos, NM, López-Bravo, A, Mínguez-Olaondo, A, Sánchez-Soblechero, A, Ros, AL, Hernández, CM, López, AA, Layos-Romero, A, Caronna, E, Torres-Ferrús, M, Alpuente, A, Pozo-Rosich, P, Belvís, R, Garcia-Azorin, D, Díaz-de-Terán, J, Guerrero-Peral, AL, Gago-Veiga, AB, Huerta-Villanueva, M. Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response. JOURNAL OF HEADACHE AND PAIN. 2025; 27(1)DOI:10.1186/s10194-025-02239-1. PMID:41315923. IF:7.900(Q1/1D).
10/11/2025 Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome
Huber, H, Arranz, J, Arslan, B, Leuzy, A, Kittel, O, Di Molfetta, G, Benejam, B, Videla, L, Barroeta, I, Soriano, LD, Maure-Blesa, L, Rodríguez-Baz, I, Infante, JEA, Illán-Gala, I, Bejanin, A, Montoliu-Gaya, L, Lleo, A, Carmona-Iragui, M, Alcolea, D, Blennow, K, Zetterberg, H, Fortea, J, Ashton, NJ. Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65882-x. PMID:41213934. IF:15.700(Q1/1D).
01/11/2025 BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans
Heredia-Lidón, A, Echeverry-Quiceno, LM, González, A, Hostalet, N, Pomarol-Clotet, E, Fortea, J, Fatjó-Vilas, M, Martínez-Abadías, N, Sevillano, X. BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 2025; 271DOI:10.1016/j.cmpb.2025.109010. PMID:40818363. IF:4.800(Q1/1D).
01/11/2025 Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
Salvadó, G, Janelidze, S, Bali, D, Dolado, AO, Therriault, J, Brum, WS, Binette, AP, Stomrud, E, Mattsson-Carlgren, N, Palmqvist, S, Coomans, EM, Teunissen, CE, van der Flier, WM, Rahmouni, N, Benzinger, TLS, Gispert, JD, Blennow, K, Dore, V, Feizpour, A, Rowe, CC, Alcolea, D, Fortea, J, Villeneuve, S, Johnson, SC, Rosa-Neto, P, Petersen, RC, Jack, CR, Schindler, SE, Suárez-Calvet, M, Ossenkoppele, R, Hansson, O. Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurology. 2025; 82(11)DOI:10.1001/jamaneurol.2025.3217. PMID:40952756. IF:21.300(Q1/1D).
01/11/2025 Associations of lifestyle factors with amyloid pathology in persons without dementia
Oomens, JE, Vos, SJB, Maserejian, NN, Boada, M, Didic, M, Engelborghs, S, Fladby, T, van der Flier, WM, Frisoni, GB, Fröhlich, L, Gill, KD, Grimmer, T, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Landau, SM, Lee, DY, Lleó, A, Martinez-Lage, P, de Mendonça, A, Meyer, PT, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sánchez-Juan, P, Santana, I, Scarmeas, N, Scheltens, P, Skoog, I, Sperling, RA, Stern, Y, Villeneuve, S, Waldemar, G, Wiltfang, J, Zetterberg, H, Alcolea, D, Allegri, RF, Altomare, D, Bateman, RJ, Baiardi, S, Baldeiras, I, Blennow, K, den Braber, A, van Buchem, MA, Byun, MS, Cerman, J, Chen, KW, Chipi, E, Day, GS, Drzezga, A, Ekblad, LL, Förster, S, Fortea, J, Freund-Levi, Y, Frings, L, Guedj, E, Habeck, CG, Handels, R, Hausner, L, Hellwig, S, Jiménez-Bonilla, JF, Juaristi, AI, Kandimalla, R, Kern, S, Kirsebom, BESB, Kornhuber, J, Legdeur, N, Levin, J, Maier, W, Marquié, M, Minatani, S, Morbelli, SD, Mroczko, B, Ntanasi, E, de Oliveira, CR, Orellana, A, Peters, O, Prabhakar, S, Ramakers, IH, Rodríguez-Rodriguez, E, Ruiz, A, Rüther, E, Sakhardande, J, Selnes, P, Silva, D, Soininen, H, Spiru, L, Takeda, A, Teunissen, CE, Tijms, BM, Vermunt, L, Wallin, ÅK, Wiels, W, Yannakoulia, M, Yi, D, Zettergren, A, Ossenkoppele, R, Verhey, FRJ, Visser, PJ, Jansen, WJ. Associations of lifestyle factors with amyloid pathology in persons without dementia. JOURNAL OF ALZHEIMERS DISEASE. 2025; 108(3)DOI:10.1177/13872877251379083. PMID:41234025. IF:3.100(Q2/5D).
01/10/2025 EXTRACELLULAR VESICLES IN CADASIL: EMERGING INSIGHTS INTO PATHOGENESIS AND BIOMARKER POTENTIAL
Bugallo-Casal, A, Muiño, E, Lopez, SB, Villatoro-González, P, Appiani, F, Sala, I, Pérez-Gayol, L, Alonso-Palomar, N, Ameal-Tedin, D, Arias-Rivas, S, Rodríguez-Yáñez, M, Santamaria-Cadavid, M, Rodríguez-Castro, E, Fernández-Cadenas, I, Labandeira-Garcia, JL, Rodriguez-Perez, AI, Campos-Perez, F. EXTRACELLULAR VESICLES IN CADASIL: EMERGING INSIGHTS INTO PATHOGENESIS AND BIOMARKER POTENTIAL. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025 Cognitive Testing in Down Syndrome: Adapting Tools for Better Dementia Diagnosis
Sandkühler, K, Soriano, LD, Fortea, J, Levin, J. Cognitive Testing in Down Syndrome: Adapting Tools for Better Dementia Diagnosis. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2025; 69(10)DOI:. PMID:. IF:2.000(Q1/1D).
02/12/2025 SynaptopathyDB integrates synaptic proteomes, genetic and phenotypic data to advance research on nervous system disorders
Sorokina, O, Dominic, D, Bayés, A, Armstrong, JD, Grant, SGN. SynaptopathyDB integrates synaptic proteomes, genetic and phenotypic data to advance research on nervous system disorders. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-26969-z. PMID:41330977. IF:3.900(Q1/2D).